stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / BIIB / Revenue

Biogen Inc. Revenue 2007–2025

Biogen Inc. (BIIB) annual revenue by fiscal year, computed from SEC filings. Compound growth +6.5%/yr over 18 years.

Fiscal yearRevenueChange (YoY)
FY 2025$9.89B+2.2%
FY 2024$9.68B-1.6%
FY 2023$9.84B-3.3%
FY 2022$10.17B-7.4%
FY 2021$10.98B-18.3%
FY 2020$13.44B-6.5%
FY 2019$14.38B+6.9%
FY 2018$13.45B+9.6%
FY 2017$12.27B+7.2%
FY 2016$11.45B+6.4%
FY 2015$10.76B+10.9%
FY 2014$9.70B+40.0%
FY 2013$6.93B+25.7%
FY 2012$5.52B+9.3%
FY 2011$5.05B+7.0%
FY 2010$4.72B+7.7%
FY 2009$4.38B+6.8%
FY 2008$4.10B+29.2%
FY 2007$3.17B

Source: Biogen Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Biogen Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Biogen Inc. — frequently asked questions

What is Biogen Inc.'s revenue?

Biogen Inc. (BIIB) reported revenue of $9.89B for fiscal year 2025, per its SEC filings.

How has Biogen Inc.'s revenue changed over time?

Between fiscal 2007 and 2025, BIIB's revenue grew at roughly 6.5% per year (compound annual rate), from $3.17B to $9.89B.

Where does this data come from?

Figures are computed from Biogen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More BIIB financial history

Full BIIB fundamentals page → · All 1,500+ companies →